Medicaid’s buying power can be harnessed to cut healthcare emissions and promote equity by embedding ESG criteria into procurement; Section 1115 waiver pilots and NHS Net Zero offer practical templates, but meaningful deployment will hinge on data systems, algorithmic governance and support for smaller suppliers.

Main Finding

Medicaid procurement can be purposefully redesigned as an ESG-integrated lever—grounded in Stakeholder Theory and the Triple Bottom Line—to reduce healthcare’s environmental footprint, advance health equity, and strengthen institutional accountability. The paper offers a practical, policy-ready roadmap (including use of Section 1115 waivers) and international benchmarking (NHS Net Zero) to demonstrate feasibility and scalability.

Key Points

• Conceptual reframing: Positions value-based procurement beyond cost containment to include environmental stewardship, social equity, and institutional accountability.
• Theoretical anchors: Integrates Stakeholder Theory and the Triple Bottom Line (TBL) to justify multi-dimensional procurement value.
• Policy instruments: Highlights Section 1115 Medicaid waivers as a flexible mechanism to pilot and scale ESG procurement reforms within Medicaid.
• Operational mechanisms: Proposes procurement levers (e.g., ESG-weighted bids, supplier ESG reporting requirements, lifecycle procurement criteria) and governance practices to embed ESG.
• Benchmarking: Uses the UK NHS Net Zero strategy as an international exemplar to illustrate potential targets, metrics, and institutional arrangements.
• Systemic framing: Treats Medicaid as a buyer with market power to shape upstream supplier behavior and incentivize greener, more equitable healthcare supply chains.
• Contributions: Advances theory by linking public healthcare procurement to climate action and equity goals; advances policy by supplying actionable pathways and regulatory options.

Data & Methods

• Methodological type: Conceptual/theoretical study with policy analysis and international benchmarking; not an original empirical evaluation.
• Evidence base: Extensive synthesis of contemporary literature in sustainable supply chain management, healthcare procurement, and ESG governance.
• Framework development: Constructs an ESG-integrated procurement framework using TBL and Stakeholder Theory as normative foundations.
• Policy analysis: Examines statutory and regulatory levers—especially Section 1115 waivers—to map feasible implementation pathways within Medicaid.
• Benchmarking approach: Compares mechanisms and targets from the NHS Net Zero program to assess feasibility and identify transferrable practices.
• Limitations noted: Relies on secondary literature and comparative policy examples; lacks primary data on implementation outcomes, provider/supplier responses, and cost-effectiveness in the U.S. Medicaid context.

Implications for AI Economics

• Measurement & data needs: Effective ESG procurement requires granular supplier-level data (emissions LCA, labor practices, spend data, procurement outcomes, health equity metrics). AI can help harmonize, impute, and validate heterogeneous ESG and lifecycle datasets for use in procurement models.
• Demand-side signaling and market shaping: Models of buyer power and supplier investment behavior can be estimated to quantify how Medicaid procurement standards (e.g., ESG weighting) change supplier pricing, technology adoption, and emissions — suitable for structural estimation and counterfactual simulations.
• Evaluation designs: Section 1115 waiver pilots create quasi-experimental or experimental opportunities (staggered rollouts, randomized procurement pilots) for causal inference on effects of ESG procurement on emissions, costs, and health equity; econometric approaches include diff-in-diff, synthetic controls, and instrumental variables.
• Optimization & algorithmic procurement: AI-driven procurement algorithms can operationalize multi-objective optimization (cost, emissions, equity) and perform supplier scoring/ranking. Economics research should examine incentive compatibility, potential for gaming, and distributional impacts when algorithmic rules guide public purchasing.
• Externalities and welfare analysis: Embedding environmental externalities into procurement requires valuation and dynamic modeling of climate and health co-benefits. AI-enabled integrated assessment and microsimulation models can help evaluate social welfare trade-offs.
• Supplier response and market structure: Machine learning classification of supplier ESG risk can inform competition analyses; models should consider entry/exit, consolidation risks, and potential effects on access and prices in Medicaid markets.
• Algorithmic fairness & governance: Using AI in procurement raises fairness and transparency concerns—models must be interpretable, auditable, and designed to avoid exacerbating inequities (e.g., suppliers from disadvantaged communities being unintentionally penalized).
• Research priorities:
  • Empirically estimate the causal impact of ESG-weighted procurement on emissions, costs, and patient outcomes.
  • Develop and validate ML-based supplier ESG scoring that is robust, interpretable, and audit-ready.
  • Design and evaluate randomized or phased procurement pilots under Section 1115 waivers.
  • Build structural models of supply-side investment responses to public procurement standards.
  • Quantify long-run welfare gains from procurement-driven decarbonization, including health co-benefits and distributional effects.
• Practical considerations for implementation:
  • Data infrastructure investments (LCA data, standardized ESG reporting) are prerequisites; AI can reduce cost but depends on quality inputs.
  • Pilot designs should include transparency, grievance mechanisms, and capacity building for small/minority suppliers to mitigate adverse equity effects.
  • Regulatory oversight and model governance are needed to ensure procurement algorithms align with public-value objectives and legal procurement constraints.

Overall, the paper maps a promising policy pathway where Medicaid’s purchasing power can be harnessed for climate and equity goals; AI and economic methods can play central roles in measurement, optimization, causal evaluation, and ensuring equitable outcomes—but require careful data, governance, and evaluation design.